Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2025-12-11
DOI
https://doi.org/10.1016/j.lanepe.2025.101562
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study

The Lancet Regional Health - Europe
Autoimmune Neurological Disorders and Treatments
article

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study

article en

Abstract

No abstract available for this paper.
The Lancet Regional Health - EuropeVol. 62
Université Claude Bernard Lyon 1 (FR), University of Udine (IT), Witten/Herdecke University (DE), Tilburg University (NL), German Center for Neurodegenerative Diseases (DE), Erasmus MC (NL), Hochschule für Angewandte Wissenschaften Kiel (DE), Christian-Albrechts-Universität zu Kiel (DE), Medizinische Hochschule Hannover (DE), Düsseldorf University Hospital (DE), Hospices Civils de Lyon (FR), Hospital Universitario 12 De Octubre (ES), University Hospital Schleswig-Holstein (DE), Centro de Investigación Biomédica en Red (ES), Hospital Clínic de Barcelona (ES), Jena University Hospital (DE), Elisabeth-TweeSteden Ziekenhuis (NL), University Hospital Ulm (DE), Barcelona School of Economics (ES), Heinrich Heine University Düsseldorf (DE), Kitasato University (JP), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)
Stichting Dioraphte
Partnerships for the goals
Openalex Percentile: Top 33%
Autoimmune Neurological Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study · The Lancet Regional Health - Europe (2025) | TGRS Research Map | TGRS